All stock lists
Credicorp Ltd. (New York Stock Exchange:BAP)
PE · Delayed Price · Currency is USD
Also listed: 0U8N.LFinancial Services · Banks - Diversified
347.93-0.06 (-0.02%)
Market cap
$27.6B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 25, 1995
Website
Insider Score
––Not scored
BAP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From BAP’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $29.44B
- Net income
- $7.34B
- Net margin
- 24.9%
Leverage20 / 20
Little or no net debt.
- Total debt
- $36.03B
- Cash
- $41.23B
- Net debt / EBITDA
- -0.46x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $43.50B
- Current liabilities
- $18.34B
- Current ratio
- 2.37
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $5.46B
- Free cash flow
- $5.17B
- FCF margin
- 17.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 79.4M
- Share growth (1y)
- -0.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BAP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 8.11 B | 7.74 B | 8.31 B | 5.29 B | 7.42 B | 6.93 B |
| Revenue Growth (YoY) | 9.27 % | 11.60 % | 25.76 % | -23.01 % | 8.87 % | 5.60 % |
| Cost of Revenue | 2.03 B | 1.73 B | 1.92 B | 1.17 B | 1.88 B | 1.90 B |
| Gross Profit | 6.07 B | 6.01 B | 6.39 B | 4.12 B | 5.54 B | 5.03 B |
| SG&A Expense | 1.55 B | 1.53 B | 1.52 B | 2.59 B | 2.02 B | 2.05 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.26 B | 3.10 B | 4.05 B | 1.42 B | 2.97 B | 2.51 B |
| Operating Income | 2.82 B | 2.91 B | 2.34 B | 2.71 B | 2.56 B | 2.52 B |
| Pretax Income | 2.81 B | 2.90 B | 2.34 B | 2.51 B | 2.56 B | 2.52 B |
| Tax Provision | 808.10 M | 807.45 M | 730.24 M | 728.31 M | 696.97 M | 704.47 M |
| Net Income | 1.97 B | 2.06 B | 1.58 B | 1.74 B | 1.82 B | 1.78 B |
| EPS (Basic) | 24.78 | 25.94 | 19.90 | 21.86 | 22.80 | 22.40 |
| EPS (Diluted) | 24.78 | 25.91 | 19.90 | 21.86 | 22.80 | 22.40 |
| Shares Outstanding | 79.41 M | 79.39 M | 79.75 M | 79.45 M | 79.91 M | 79.37 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.